$NNVC Recent Headlines Pigs will get slaughtered
Post# of 94143
Posted On: 03/03/2014 9:37:02 AM
$NNVC Recent Headlines
Pigs will get slaughtered on swine-flu stocks 5:27 p.m. April 30, 2009 - Chuck Jaffe
10-Q: NANOVIRICIDES, INC. 4:28 p.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
NanoViricides responds to SA article, resumes trading 1:59 p.m. Feb. 11, 2014 - Seeking Alpha
UPDATE: NanoViricides Calls SeekingAlpha Article 'Baseless,' 'Inaccurate' 12:30 p.m. Feb. 11, 2014 - benzinga.com
Nanoviricides plunges following SA article 9:58 a.m. Feb. 11, 2014 - Seeking Alpha
Nanoviricides: House Of Cards With -80% Downside, 'Strong Sell' Recommendation 9:00 a.m. Feb. 11, 2014 - Seeking Alpha
NanoViricides rises on FluCide safety data 8:11 a.m. Dec. 2, 2013 - Seeking Alpha
10-Q: NANOVIRICIDES, INC. 5:05 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
NanoViricides Incorporated: A Biotech Innovator Bound Only By Its Own Ambition 3:32 p.m. Nov. 4, 2013 - Seeking Alpha
NanoViricides Reports FluCide Well-Tolerated in non-GLP Small Animal Tox Study 5:15 a.m. Oct. 21, 2013 - benzinga.com
10-K/A: NANOVIRICIDES, INC. 9:40 a.m. Oct. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: NANOVIRICIDES, INC. 3:11 p.m. Sept. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)
NanoViricides Improves HIVCide Drug Candidate in Cell Culture Studies 5:12 a.m. Sept. 16, 2013 - benzinga.com
10-Q: NANOVIRICIDES, INC. 4:31 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
NanoViricides, Inc. Reports its President & Chairman Dr. Diwan Purchased its Common Stock in the Open Market 7:02 a.m. Feb. 26, 2014 - BusinessWire - BZX
NanoViricides Reports that it is Evaluating Purchase of the New Facility and cGMP Pilot Production Plant instead of a Lease 7:01 a.m. Feb. 20, 2014 - BusinessWire - BZX
NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Clinical Trials of its First Two Drug Candidates 7:01 a.m. Feb. 18, 2014 - BusinessWire - BZX
NanoViricides, Inc. Demands Retraction of the Baseless and Inaccurate Libelous Article by an Anonymous Short Seller Posted on SeekingAlpha Website 10:06 a.m. Feb. 14, 2014 - BusinessWire - BZX
NanoViricides, Inc. Demands Retraction of the Baseless and Inaccurate Libelous Article by an Anonymous Short Seller Posted on SeekingAlpha Website 7:00 a.m. Feb. 14, 2014 - BusinessWire - BZX
Harwood Feffer LLP Announces Investigation of NanoViricides, Inc. 8:30 p.m. Feb. 12, 2014 - PR Newswire - PRF
Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of NanoViricides, Inc. 5:33 p.m. Feb. 12, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NanoViricides, Inc. - NNVC 6:49 p.m. Feb. 11, 2014 - PR Newswire - PRF
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of NanoViricides, Inc. 4:05 p.m. Feb. 11, 2014 - PR Newswire - PRF
NanoViricides CEO Dr. Seymour to be Interviewed on Radio by Yorba Media at 2PM Eastern 1:50 p.m. Feb. 11, 2014 - BusinessWire - BZX
NanoViricides, Inc. Responds to Baseless Seeking Alpha Article 1:30 p.m. Feb. 11, 2014 - BusinessWire - BZX
NanoViricides Signs Agreement with Viroclinics Biosciences BV for Testing of Various NanoViricides Against Specific Viruses of Current Concern 7:01 a.m. Feb. 4, 2014 - BusinessWire - BZX
NanoViricides Reports Construction of its New Facility and cGMP Pilot Production Plant is Nearing Completion, also Provides Details of its $20 Million Registered Direct Offering 7:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
NanoViricides Announces that It Has Raised $20 Million in a Registered Direct Offering 9:18 a.m. Jan. 21, 2014 - BusinessWire - BZX
Recap of NanoViricides, Inc. CEO Dr. Eugene Seymour Clear Channel Business Talk Radio Interview 12:18 p.m. Dec. 23, 2013 - Marketwire
NanoViricides CEO Dr. Eugene Seymour to Be Interviewed on Clear Channel DFW 1190AM 9:29 a.m. Dec. 18, 2013 - Marketwire
NanoViricides Announces that its Annual Meeting was held on December 9th, 2013; the CEO Presentation is available on the Redesigned Website 8:52 a.m. Dec. 11, 2013 - BusinessWire
NanoViricides, Inc. Reports Excellent Safety Profile of Its Broad-Spectrum anti-Influenza Drug Candidate, FluCide(TM) , in a Non-GLP Study 7:00 a.m. Dec. 2, 2013 - BusinessWire
Dengue Fever Case in New York Highlights Importance of NanoViricides' DengueCide(R) Development Program 2:37 p.m. Nov. 21, 2013 - BusinessWire
NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Clinical Trials of its First Drug Candidate 7:00 a.m. Nov. 18, 2013 - BusinessWire
Pigs will get slaughtered on swine-flu stocks 5:27 p.m. April 30, 2009 - Chuck Jaffe
10-Q: NANOVIRICIDES, INC. 4:28 p.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
NanoViricides responds to SA article, resumes trading 1:59 p.m. Feb. 11, 2014 - Seeking Alpha
UPDATE: NanoViricides Calls SeekingAlpha Article 'Baseless,' 'Inaccurate' 12:30 p.m. Feb. 11, 2014 - benzinga.com
Nanoviricides plunges following SA article 9:58 a.m. Feb. 11, 2014 - Seeking Alpha
Nanoviricides: House Of Cards With -80% Downside, 'Strong Sell' Recommendation 9:00 a.m. Feb. 11, 2014 - Seeking Alpha
NanoViricides rises on FluCide safety data 8:11 a.m. Dec. 2, 2013 - Seeking Alpha
10-Q: NANOVIRICIDES, INC. 5:05 p.m. Nov. 14, 2013 - Edgar Online - (EDG = 10Q, 10K)
NanoViricides Incorporated: A Biotech Innovator Bound Only By Its Own Ambition 3:32 p.m. Nov. 4, 2013 - Seeking Alpha
NanoViricides Reports FluCide Well-Tolerated in non-GLP Small Animal Tox Study 5:15 a.m. Oct. 21, 2013 - benzinga.com
10-K/A: NANOVIRICIDES, INC. 9:40 a.m. Oct. 8, 2013 - Edgar Online - (EDG = 10Q, 10K)
10-K: NANOVIRICIDES, INC. 3:11 p.m. Sept. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)
NanoViricides Improves HIVCide Drug Candidate in Cell Culture Studies 5:12 a.m. Sept. 16, 2013 - benzinga.com
10-Q: NANOVIRICIDES, INC. 4:31 p.m. May 15, 2013 - Edgar Online - (EDG = 10Q, 10K)
NanoViricides, Inc. Reports its President & Chairman Dr. Diwan Purchased its Common Stock in the Open Market 7:02 a.m. Feb. 26, 2014 - BusinessWire - BZX
NanoViricides Reports that it is Evaluating Purchase of the New Facility and cGMP Pilot Production Plant instead of a Lease 7:01 a.m. Feb. 20, 2014 - BusinessWire - BZX
NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Clinical Trials of its First Two Drug Candidates 7:01 a.m. Feb. 18, 2014 - BusinessWire - BZX
NanoViricides, Inc. Demands Retraction of the Baseless and Inaccurate Libelous Article by an Anonymous Short Seller Posted on SeekingAlpha Website 10:06 a.m. Feb. 14, 2014 - BusinessWire - BZX
NanoViricides, Inc. Demands Retraction of the Baseless and Inaccurate Libelous Article by an Anonymous Short Seller Posted on SeekingAlpha Website 7:00 a.m. Feb. 14, 2014 - BusinessWire - BZX
Harwood Feffer LLP Announces Investigation of NanoViricides, Inc. 8:30 p.m. Feb. 12, 2014 - PR Newswire - PRF
Law Offices of Howard G. Smith Announces Investigation on Behalf of Investors of NanoViricides, Inc. 5:33 p.m. Feb. 12, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NanoViricides, Inc. - NNVC 6:49 p.m. Feb. 11, 2014 - PR Newswire - PRF
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of NanoViricides, Inc. 4:05 p.m. Feb. 11, 2014 - PR Newswire - PRF
NanoViricides CEO Dr. Seymour to be Interviewed on Radio by Yorba Media at 2PM Eastern 1:50 p.m. Feb. 11, 2014 - BusinessWire - BZX
NanoViricides, Inc. Responds to Baseless Seeking Alpha Article 1:30 p.m. Feb. 11, 2014 - BusinessWire - BZX
NanoViricides Signs Agreement with Viroclinics Biosciences BV for Testing of Various NanoViricides Against Specific Viruses of Current Concern 7:01 a.m. Feb. 4, 2014 - BusinessWire - BZX
NanoViricides Reports Construction of its New Facility and cGMP Pilot Production Plant is Nearing Completion, also Provides Details of its $20 Million Registered Direct Offering 7:00 a.m. Jan. 27, 2014 - BusinessWire - BZX
NanoViricides Announces that It Has Raised $20 Million in a Registered Direct Offering 9:18 a.m. Jan. 21, 2014 - BusinessWire - BZX
Recap of NanoViricides, Inc. CEO Dr. Eugene Seymour Clear Channel Business Talk Radio Interview 12:18 p.m. Dec. 23, 2013 - Marketwire
NanoViricides CEO Dr. Eugene Seymour to Be Interviewed on Clear Channel DFW 1190AM 9:29 a.m. Dec. 18, 2013 - Marketwire
NanoViricides Announces that its Annual Meeting was held on December 9th, 2013; the CEO Presentation is available on the Redesigned Website 8:52 a.m. Dec. 11, 2013 - BusinessWire
NanoViricides, Inc. Reports Excellent Safety Profile of Its Broad-Spectrum anti-Influenza Drug Candidate, FluCide(TM) , in a Non-GLP Study 7:00 a.m. Dec. 2, 2013 - BusinessWire
Dengue Fever Case in New York Highlights Importance of NanoViricides' DengueCide(R) Development Program 2:37 p.m. Nov. 21, 2013 - BusinessWire
NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Clinical Trials of its First Drug Candidate 7:00 a.m. Nov. 18, 2013 - BusinessWire
(0)
(0)Scroll down for more posts ▼